Potential deaths averted in USA by replacing cigarettes with e-cigarettes

Tobacco Control

Volumn 27, Issue 1, 2018, Pages 18-25

  Levy, David T ^a   Borland, Ron ^b   Lindblom, Eric N ^c   Goniewicz, Maciej L ^d   Meza, Rafael ^e   Holford, Theodore R ^f   Yuan, Zhe ^a   Luo, Yuying ^a   O’Connor, Richard J ^d   Niaura, Raymond ^g   Abrams, David B ^a,g  

^a GEORGETOWN UNIVERSITY   (United States)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c GEORGETOWN UNIVERSITY LAW CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f YALE UNIVERSITY   (United States)

^g American Legacy Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DEATH; FEMALE; LIFE EXPECTANCY; MALE; MORTALITY; NONHUMAN; PUBLIC HEALTH; VAPING; ADOLESCENT; ADULT; AGE; AGED; CIGARETTE SMOKING; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; HUMAN; MIDDLE AGED; PREMATURE MORTALITY; SMOKING; SMOKING CESSATION; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CIGARETTE SMOKING; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY, PREMATURE; PUBLIC HEALTH; SMOKERS; SMOKING; SMOKING CESSATION; UNITED STATES; VAPING; YOUNG ADULT;

EID: 85041725905     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2017-053759     Document Type: Article

References (71)

1. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA 2014;311:164–71.
2. Levy DT, Meza R, Zhang Y, et al. Gauging the Effect of U.S. Tobacco Control Policies From 1965 Through 2014 Using SimSmoke. Am J Prev Med 2016;50:535–42.
3. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013;368:341–50.
4. Thun MJ, Lopez AD, Hartge P. Smoking-related mortality in the United States. N Engl J Med 2013;18:368.
5. Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality--beyond established causes. N Engl J Med 2015;372:631–40.
6. U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta, GA. 2014.
7. Warner KE. Tobacco control policies and their impacts. Past, present, and future. Ann Am Thorac Soc 2014;11:227–30.
8. Lykke M, Pisinger C, Glümer C. Ready for a goodbye to tobacco? - Assessment of support for endgame strategies on smoking among adults in a Danish regional health survey. Prev Med 2016;83:5–10.
9. Branston JR, Sweanor D. Big tobacco, E-cigarettes, and a road to the smoking endgame. Int J Drug Policy 2016;29:14–18.
10. Cobiac LJ, Ikeda T, Nghiem N, et al. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame. Tob Control 2015;24:e154–60.
11. Hurt RD, Murphy JG, Dunn WF. Did we finally slay the evil dragon of cigarette smoking in the late 20th century?: unfortunately, the answer is no - the dragon is still alive and well in the 21st century and living in the third world. Shame on us!. Chest 2014;146:1438–43.
12. Kozlowski LT. Prospects for a nicotine-reduction strategy in the cigarette endgame: Alternative tobacco harm reduction scenarios. Int J Drug Policy 2015;26:543–7.
13. Malone R, McDaniel P, Smith E. It is time to plan the tobacco endgame. BMJ 2014;348:g1453.
14. Pearson AL, van der Deen FS, Wilson N, et al. Theoretical impacts of a range of major tobacco retail outlet reduction interventions: modelling results in a country with a smoke-free nation goal. Tob Control 2015;24:e32–8.
15. Thomas BP, Gostin LO. Tobacco endgame strategies: challenges in ethics and law. Tob Control 2013;22(Suppl 1):i55–7.
16. Benowitz NL, Donny EC, Hatsukami DK. Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game. Addiction 2017;112:6–7.
17. Kozlowski LT, Abrams DB. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction. BMC Public Health 2016;16:432.
18. Abrams DB. Promise and peril of e-cigarettes: can disruptive technology make cigarettes obsolete? JAMA 2014;311:135–6.
19. Levy DT, Cummings KM, Villanti AC, et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction 2017;112:8–17.
20. Levy DT, Borland R, Villanti AC, et al. The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States. Nicotine Tob Res 2017;19:149–59.
21. Warner KE. An endgame for tobacco? Tob Control 2013;22(Suppl 1):i3–5.
22. Fairchild AL, Bayer R, Colgrove J. The renormalization of smoking? E-cigarettes and the tobacco “endgame”. N Engl J Med 2014;370:293–5.
23. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016;4:116–28.
24. Kalkhoran S, Grana RA, Neilands TB, et al. Dual use of smokeless tobacco or e-cigarettes with cigarettes and cessation. Am J Health Behav 2015;39:277–84.
25. McKee M, Chapman S, Daube M, et al. The debate on electronic cigarettes. Lancet 2014;384:2107.
26. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res 2015;17:704–9.
27. Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP, 2016.
28. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133–9.
29. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control 2017;26:e23–8.
30. Glasser AM, Collins L, Pearson JL, et al. Overview of electronic nicotine delivery systems: A systematic review. Am J Prev Med 2017;52:e33–66.
31. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a Cross-sectional Study. Ann Intern Med 2017;166:390.
32. Goniewicz ML, Gawron M, Smith DM, et al. Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study. Nicotine Tob Res 2017;19:160–7.
33. Farsalinos KE, Spyrou A, Tsimopoulou K, et al. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep 2014;4:4133.
34. Dawkins L, Turner J, Roberts A, et al.’Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 2013;108:1115–25.
35. Holford TR, Levy DT, McKay LA, et al. Patterns of birth cohort-specific smoking histories, 1965-2009. Am J Prev Med 2014;46:e31–7.
36. Rosenberg MA, Feuer EJ, Yu B, et al. Chapter 3: Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Anal 2012;32(Suppl 1):S25–38.
37. Institute of Medicine. Public health implications of raising the minimum age of legal access to tobacco products. Washingon, DC: National Academy Press, 2015.
38. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519.
39. Villanti AC, Pearson JL, Glasser AM, et al. Frequency of youth e-cigarette and tobacco use patterns in the U.S.: Measurement precision is critical to inform public health. Nicotine Tob Res 2016:ntw388.
40. Delnevo CD, Giovenco DP, Steinberg MB, et al. Patterns of Electronic Cigarette Use Among Adults in the United States. Nicotine Tob Res 2016;18:715–9.
41. Warner KE. Frequency of E-Cigarette Use and Cigarette Smoking by American Students in 2014. Am J Prev Med 2016;51:179–84.
42. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology 2014;231:401–7.
43. Spindle TR, Breland AB, Karaoghlanian NV, et al. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects. Nicotine Tob Res 2015;17:142–9.
44. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15:267–70.
45. Liu G, Wasserman E, Kong L, et al. A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study. Prev Med 2017.
46. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014;20:218–25.
47. Glantz SA. Need for examination of broader range of risks when predicting the effects of new tobacco products. Nicotine Tob Res 2017;19:266–7.
48. Glantz SA. UCSF Blog, 2017. https://tobacco.ucsf.edu/evidence-e-cigs-increase-cardiovascular-risk-keeps-piling-effects-heart-rhythm-and-oxidative-stress
49. Levy DT, Borland R, Villanti AC, et al. The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States. Nicotine Tob Res 2017;19:149–59.
50. Czogala J, Goniewicz ML, Fidelus B, et al. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res 2014;16:655–62.
51. McAuley TR, Hopke PK, Zhao J, et al. Comparison of the effects of e-cigarette vapor and cigarette smoke on indoor air quality. Inhal Toxicol 2012;24:850–7.
52. Cobb CO, Villanti AC, Graham AL, et al. Markov Modeling to Estimate the Population Impact of Emerging Tobacco Products: A Proof-of-Concept Study. Tob Regul Sci 2015;1:129–41.
53. Cherng ST, Tam J, Christine PJ, et al. Modeling the Effects of E-cigarettes on Smoking Behavior: Implications for Future Adult Smoking Prevalence. Epidemiology 2016;27:819–26.
54. Kalkhoran S, Glantz SA. Modeling the Health Effects of Expanding e-Cigarette Sales in the United States and United Kingdom: A Monte Carlo Analysis. JAMA Intern Med 2015;175:1671–80.
55. King BA, Patel R, Nguyen KH, et al. Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res 2015;17:219–27.
56. Marynak KL, Gammon DG, King BA, et al. National and State Trends in Sales of Cigarettes and E-Cigarettes, U.S., 2011-2015. Am J Prev Med 2017;53:96–101.
57. Delnevo CD, Hrywna M, Foulds J, et al. Cigar use before and after a cigarette excise tax increase in New Jersey. Addict Behav 2004;29:1799–807.
58. Levy D, Mohlman MK, Zhang Y. Estimating the Potential Impact of Tobacco Control Policies on Adverse Maternal and Child Health Outcomes in the United States Using the SimSmoke Tobacco Control Policy Simulation Model. Nicotine Tob Res 2016;18:1240–9.
59. Ahmad S, Franz GA. Raising taxes to reduce smoking prevalence in the US: a simulation of the anticipated health and economic impacts. Public Health 2008;122:3–10.
60. Levy DT, Mabry PL, Graham AL, et al. Reaching Healthy People 2010 by 2013: A SimSmoke simulation. Am J Prev Med 2010;38(3 Suppl):S373–81.
61. Levy DT, Mays D, Yuan Z, et al. Public health benefits from pictorial health warnings on US cigarette packs: a SimSmoke simulation. Tob Control 2017;26:649–55.
62. Levy DT, Lindblom EN, Fleischer NL, et al. Public Health Effects of Restricting Retail Tobacco Product Displays and Ads. Tob Regul Sci 2015;1:61–75.
63. Donny EC, Hatsukami DK, Benowitz NL, et al. Reduced nicotine product standards for combustible tobacco: building an empirical basis for effective regulation. Prev Med 2014;68:17–22.
64. Smith TT, Sved AF, Hatsukami DK, et al. Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach. Prev Med 2014;68:23–8.
65. Hatsukami DK, Luo X, Dick L, et al. Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trial. Addiction 2017;112:156–67.
66. Levy DT, Pearson JL, Villanti AC, et al. Modeling the future effects of a menthol ban on smoking prevalence and smoking-attributable deaths in the United States. Am J Public Health 2011;101:1236–40.
67. Chaloupka FJ, Sweanor D, Warner KE. Differential taxes for differential risks–toward reduced harm from nicotine-yielding products. N Engl J Med 2015;373:594–7.
68. Stoklosa M, Drope J, Chaloupka FJ. Prices and E-Cigarette Demand: Evidence From the European Union. Nicotine Tob Res 2016;18:1973–80.
69. Czoli CD, Goniewicz M, Islam T, et al. Consumer preferences for electronic cigarettes: results from a discrete choice experiment. Tob Control 2016;25:e30–6.
70. McDaniel PA, Smith EA, Malone RE. Philip Morris’s Project Sunrise: weakening tobacco control by working with it. Tob Control 2006;15:215–23.
71. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. Geneva: World Health Organization 2008.